Volker Heinemann
ORCID: 0000-0002-1349-3321Also affiliated with Comprehensive Cancer Center Mainfranken, Centre de Coopération Universitaire Franco-Bavarois, German Centre for Cardiovascular Research, Ludwig-Maximilians-Universität München
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Prolonged Survival of Patients Receiving Trastuzumab beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)”.
Steffen Kahlert, Wolfgang Siekiera, Michael Untch, Bernhard Heinrich, Volker Heinemann +1 more
Shu Cao, Dongyun Yang, Joshua Millstein, Alberto Puccini, Fotios Loupakis +12 more
Xianlu Laura Peng, Michael P. East, Ian C. McCabe, Grace C. Stroman, Madison R. Jenner +16 more
Bert H. O’Neil, Sebastian Stintzing, Fang‐Shu Ou, Tyler Zemla, Donna Niedzwiecki +18 more